RecruitingPhase 3NCT05392894

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

Studying Sickle cell disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
King's College Hospital NHS Trust
Principal Investigator
Ann-Marie Murtagh
King's College Hospitals NHS Foundation Trust
Intervention
Haploidentical stem cell transplantation(procedure)
Enrollment
120 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2027

Study locations (1)

Collaborators

King's College London · University of Sheffield · Sheffield Teaching Hospitals NHS Foundation Trust · Imperial College Healthcare NHS Trust · Guy's and St Thomas' NHS Foundation Trust · University College London Hospitals · Manchester University NHS Foundation Trust · St George's University Hospitals NHS Foundation Trust · Barts & The London NHS Trust · National Institute for Health Research, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05392894 on ClinicalTrials.gov

Other trials for Sickle cell disease

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell disease →

← Back to all trials